Direxion FundsLeveraged EquityLABU · NYSE Arca

Direxion Daily S&P Biotech Bull 3X ETF (LABU)

Compare Leveraged & Inverse ETFs Compare with others

Price: $247.22; —30 Oct 2026
Assets: $616.2M; Total net assets
Expense ratio: 0.96%; Category 0.00%
Yield: 0.34%; Trailing distributions

1Y return: 93.9%+106.4%; Category -12.6%
3Y CAGR: 69.3%+37.9%; Category 31.4%
5Y CAGR: -25.1%-27.9%; Category 2.8%

Loading NAV history…

Direxion Daily S&P Biotech Bull 3X ETF

Calendar-year returns

Fund only: no comparison series covers this fund's history.

Risk statistics

Five years of daily closes. Risk-free rate 4% a year.

Standard deviation: —
Maximum drawdown: —
Sharpe ratio: —
Sortino ratio: —
Beta: —
Alpha: —
R²: —
Information ratio: —
Upside capture: —
Downside capture: —
Tracking error: —

Trailing returns compared with benchmark
Period	1M	3M	6M	YTD	1Y	3YCAGR	5YCAGR	10YCAGR	LaunchCAGR
ETF	-7.0%	+8.7%	+42.4%	+55.1%	+93.9%	+69.3%	-25.1%	-8.3%	-19.7%
Leveraged Equity average	-23.8%	-14.7%	-17.9%	-7.1%	-12.6%	31.4%	2.8%	9.4%	-20.3%
Difference	+16.8%	+23.4%	+60.3%	+62.2%	+106.4%	+37.9%	-27.9%	-17.7%	+0.5%

Holdings

The 1 largest positions make up 0.5% of the fund.

Top holdings

Largest holdings by weight
Ticker	Holding	Weight
TWST	Twist Bioscience Corp	0.55%

Portfolio valuation

Weighted averages of what the fund holds.

P/E: —
P/B: 4.9
P/S: 8.1
P/CF: —

Sector allocation

Share of the equity the fund holds.

Health care99.3%
Financial services0.7%

Asset mix

Other76.7%
Stocks24.7%

ETF details

Issuer: Direxion Funds
Category: Equity · Leveraged Equity
Ticker: LABU
Exchange: NYSE Arca
Inception: 28 May 2015 (11.4 years)
Structure: Exchange Traded Fund
Expense ratio: 0.96% (category 0.00%)
Holdings turnover: 107%
Distribution yield: 0.34%
Beta, 3 years: 3.16
Total net assets: $616.2M

Prices and returns as of 30 Oct 2026; total return with distributions reinvested, before brokerage and taxes. Not investment advice.

Other leveraged equity ETFs

Other ETFs in the Leveraged Equity category.

Compare Leveraged & Inverse ETFs